Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically ...

A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study ...

As Art Chansky writes, UNC's 73-65 loss at Pittsburgh on Tuesday night proved the Panthers are the more resilient team.

After being trapped in the Koury Natatorium for two hours, then-sophomore Matt Jones' game day smelled like chlorine. But near the Dean E. Smith Center, then-juniors Abby Moore and Caroline Sevier ...

Five-star recruit Caleb Wilson announced his commitment to UNC basketball early Friday morning. Here's what it means for ...

UNC alum Dyami Brown has waited his turn with the Washington Commanders just as he did in three seasons with the Tar Heels.

Senior writer Megan Smith traveled to Duke University to ask students in K-Ville what it's like to tent for weeks ahead of ...

The New England Patriots are parting ways with safeties coach Brian Belichick, ESPN reported Tuesday. Belichick, the youngest ...

Here is everything you need to know about UNC vs. Boston College, including TV and streaming options for the game.

GZERO Publisher Evan Solomon writes that Donald Trump’s planned tariffs mean the US and Canada are headed for a trade war ...

Five-star forward Caleb Wilson, the highest-ranked uncommitted 2025 recruit, announced late Thursday that he will play at ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other safe stocks to ...